Multiple mechanisms in the motor responses of the guinea‐pig isolated urinary bladder to bradykinin
Open Access
- 1 October 1989
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 98 (2), 619-629
- https://doi.org/10.1111/j.1476-5381.1989.tb12636.x
Abstract
1 Bradykinin (1 nM-1 μm) produced a contraction of bladder strips excised from the dome of the guinea-pig urinary bladder, an effect which was greatly enhanced by removal of the mucosal layer or by thiorphan (10 μm). All subsequent experiments were performed in mucosa-free strips and in the presence of thiorphan. 2 In carbachol (5 μm)-contracted strips, bradykinin produced a concentration (1 nM-1 μm)-dependent transient relaxation. 3 Kallidin was slightly more potent than bradykinin in producing a contraction and a relaxation of the carbachol-induced tone. By contrast, [des-Arg9]-bradykinin, a selective B1 receptor agonist was barely effective up to 1 μm. 4 The contractile response to bradykinin was: (a) unaffected by either tetrodotoxin (1 μm), in vitro capsaicin desensitization (10 μm for 30 min) or apamin (0.1 μm); (b) antagonized by indomethacin (5 μm), the prostaglandin receptor antagonist SC-19220 (100 μm) or the B2 receptor antagonist [D-Arg0, Hyp3, Thi5,8, Phe7]-bradykinin (10 μm) and (c) almost abolished by nifedipine (1 μm). 5 The antagonism of the contractile response to bradykinin produced by indomethacin and SC-19220 was non-additive while that produced by indomethacin and the B2 receptor antagonist was additive. 6 The relaxant response to bradykinin was unaffected by tetrodotoxin, in vitro capsaicin desensitization or indomethacin but antagonized in a competitive manner by the B2 receptor antagonist. Further, this response was abolished by apamin (0.1 μm) but unaffected by glibenclamide (1 μm). 7 Bradykinin (10 μm) produced a consistent release of calcitonin gene-related peptide-like immunoreactivity (CGRP-LI) but not substance P-LI from the guinea-pig bladder muscle. CGRP-LI release by bradykinin was greatly reduced in bladders exposed to indomethacin. [des-Arg9]-bradykinin (10 μm) was ineffective. 8 We conclude that: (a) bradykinin-induced contraction involves activation of both B2 receptors and prostanoid synthesis, via distinct mechanisms which act by inducing calcium influx via nifedipine-sensitive channels; (b) bradykinin-induced relaxation involves activation of B2 receptors and opening of apamin-sensitive potassium channels; (c) bradykinin stimulates sensory nerves in this tissue largely via prostanoid production.This publication has 48 references indexed in Scilit:
- Multiple B2 kinin receptors m mammalian tissuesTrends in Pharmacological Sciences, 1988
- The sensory-efferent function of capsaicin-sensitive sensory neuronsGeneral Pharmacology: The Vascular System, 1988
- The pharmacology of potassium channels and their therapeutic potentialTrends in Pharmacological Sciences, 1988
- Epicardial application of bradykinin elicits pressor effects and tachycardia in guinea pigs. Possible mechanismsPeptides, 1987
- The presence of mucosa reduces the contractile response of the guinea-pig urinary bladder to substance PJournal of Pharmacy and Pharmacology, 1987
- Bradykinin highlights the role of phospholipid metabolism in the control of nerve excitabilityTrends in Neurosciences, 1987
- Contribution of prostaglandin E2 to bradykinin-induced contraction in rabbit urinary detrusor.The Japanese Journal of Pharmacology, 1987
- Response of rabbit detrusor muscle to bradykininLife Sciences, 1981
- The use of preparations of urinary bladder smooth muscle for bioassay of and discrimination between polypeptidesNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1973